You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
EFFICACY AND SAFETY OF IMATINIB: AN OLD FRIEND FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-HPS-029
- By: MONTERO-PéREZ, Olalla (HOSPITAL, PHARMACY SERVICE, Spain)
- Co-author(s): Olalla Montero-Pérez: PHARMACY SERVICE, HOSPITAL, HUELVA, Spain
Ernesto Sánchez-Gómez: PHARMACY SERVICE, HOSPITAL, HUELVA, Spain
Ana Peláez-Bejarano: PHARMACY SERVICE, HOSPITAL, HUELVA, Spain
Ignacio García-Giménez: PHARMACY SERVICE, HOSPITAL, HUELVA, Spain
Maria Dolores Santos-Rubio: PHARMACY SERVICE, HOSPITAL, HUELVA, Spain - Abstract:
Background
Chronic myeloid leukemia(CML) represents 20% of the leukemias. The commercialization of Imatinib fully changed the prognosis of the disease at that moment and, years later, new selective inhibitors of the BCR-ABL tyrosine kinase(ITK) were developed and the use of Imatinib has decreasedPurpose
To analyse the efficacy and safety of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026